| Literature DB >> 35416931 |
Miguel Sánchez-Álvarez1, Miguel A Del Pozo1.
Abstract
Programmed cell death-ligand 1 (PD-L1)-mediated T cell inhibition through PD-1 is a key checkpoint frequently exploited by tumors to evade immunity. In this issue, Wang et al. (2022. J. Cell Biol.https://doi.org/10.1083/jcb.202108083) reveal an unexpected role for PD-L1 in promoting tumor cell front-rear polarity and directionally persistent cell migration, independently of PD-1.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35416931 PMCID: PMC9011200 DOI: 10.1083/jcb.202203137
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539